Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS: NWBO · Delayed Price · USD
0.468
-0.004 (-0.87%)
Apr 24, 2024, 12:22 PM EDT - Market open
Northwest Biotherapeutics Market Cap
Northwest Biotherapeutics has a market cap or net worth of $556.91 million as of April 24, 2024. Its market cap has decreased by -4.05% in one year.
Market Cap
556.91M
Enterprise Value
605.22M
1-Year Change
-4.05%
Ranking
n/a
Category
Stock Price
$0.47
Market Cap Chart
Since December 31, 2001, Northwest Biotherapeutics's market cap has increased from $84.90M to $556.91M, an increase of 555.96%. That is a compound annual growth rate of 8.79%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 561.70M | -1.66% |
Apr 22, 2024 | 571.20M | - |
Apr 19, 2024 | 571.20M | -5.88% |
Apr 18, 2024 | 606.90M | 1.79% |
Apr 17, 2024 | 596.20M | -0.78% |
Apr 16, 2024 | 600.90M | 0.59% |
Apr 15, 2024 | 597.40M | -3.46% |
Apr 12, 2024 | 618.80M | 0.78% |
Apr 11, 2024 | 614.00M | -0.39% |
Apr 10, 2024 | 616.40M | -2.27% |
Apr 9, 2024 | 630.70M | -1.30% |
Apr 8, 2024 | 639.00M | -0.93% |
Apr 5, 2024 | 645.00M | -0.54% |
Apr 4, 2024 | 648.50M | -0.92% |
Apr 3, 2024 | 654.50M | 0.55% |
Apr 2, 2024 | 650.90M | 5.19% |
Apr 1, 2024 | 618.80M | 0.19% |
Mar 28, 2024 | 617.60M | -13.50% |
Mar 27, 2024 | 714.00M | 12.99% |
Mar 26, 2024 | 631.90M | 3.51% |
Mar 25, 2024 | 610.50M | 6.21% |
Mar 22, 2024 | 574.80M | -0.40% |
Mar 21, 2024 | 577.10M | -0.62% |
Mar 20, 2024 | 580.70M | -4.32% |
Mar 19, 2024 | 606.90M | -1.73% |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 695.32B |
Novo Nordisk | 564.00B |
UnitedHealth Group | 452.88B |
Johnson & Johnson | 359.35B |
Merck & Co. | 321.49B |
AbbVie | 297.27B |
AstraZeneca | 217.39B |
Thermo Fisher | 209.32B |